Connections between genetics and clinical data: Role of mcp-1, cftr, and spink-1 in the setting of acute, acute recurrent, and chronic pancreatitis

American Journal of Gastroenterology

Volumn 105, Issue 1, 2010, Pages 199-206

  Cavestro, Giulia Martina ^a   Zuppardo, Raffaella Alessia ^a   Bertolini, Simone ^a   Sereni, Giuliana ^a   Frulloni, Luca ^b   Okolicsanyi, Stefano ^a   Calzolari, Cristina ^a   Singh, Satish K ^c   Sianesi, Mario ^d   Del Rio, Paolo ^d   Leandro, Gioacchino ^a   Franzè, Angelo ^e   Di Mario, Francesco ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

^e UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SERINE PROTEASE INHIBITOR KAZAL TYPE 1; SERINE PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ACUTE DISEASE; AGED; ALLELES; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CONFIDENCE INTERVALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; ODDS RATIO; PANCREATITIS; PHENOTYPE; POLYMORPHISM, GENETIC; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73849086221     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.611     Document Type: Article

References (68)

1. Frossard JL, Steer M L, Pastor C M. Acute pan creatitis. Lancet 2008; 371: 143-152
2. Whitcomb DC. Acute Pancreatitis. N Engl J Med 2006;354:2142-2150
3. Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet 2003;361:1447-1455
4. Badalov N, Baradarian R, Iswara K et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007;5:648-661
5. Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379-2400
6. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring oflacute pancreatitis. Lancet 1989;22:201-205
7. Beger HG, Rau BM. Severe acute pancreatitis: clinical course and management. World J Gastroenterol 2007;13:5043-5051
8. Papachristou G I, Clermont G, Sharma A et al. Risk and markers of severe acute pancreatitis. Gastroenterol Clin N Am 2007;36:277-296
9. Sharma M, Banerjee D, Garg P K. Characterization of newer subgroups of fulminant and subfulminant pancreatitis associated with a high early mortality. Am J Gastroenterol 2007;102:2688-2695
10. Suazo-Baráhona J, Carmona-Sánchez R, Robles-Díaz G et al. Ob esity: a risk factor for severe acute biliary and alcoholic pancreatitis. Am J Gastroenterol 1998;93:1324-1328
11. Yadav D, Agarwal N, Pitchumoni C S. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol 2002;97:1309-1318
12. Somogyi L, Martin SP, Venkatesan Th et al. Recurrent acute pancreatitis: an algorithmic approach to identification and elimination of inciting factors. Gastroenterology 2001;120:708-717
13. Somogyi L, Martin SP, Ulrich C D. Recurrent acute pan creatitis. Curr Treat Options Gastroenterol 2001; 4: 361-368
14. Whitcomb D C, Yadav D, Adam S et al. North American Pancreatic Study Group. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology 2008;8:520-531
15. Mariani A, Testoni PA. Is acute recurrent pancreatitis a chronic disease? World J Gastroenterol 2008;14:995-998
16. Mergener K, Baillie J. Chronic pancreatitis. Lancet 1997; 350: 1379-1385
17. Steer M L, Waxam I, fireedman S. Chronicpan creatitis. N Engl J M ed 1995;332:1482-1490
18. Bornman PC, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system: chronic pancreatitis. BMJ 2001; 322: 660-663
19. Behrman SW, Fowler ES. Pathophysiology of chronic pancreatitis. Surg Clin North Am 2007;87:1309-1324
20. Sandhu B S, Hackworth W A, Stevens S et al.R ecu rren t flares of pancreatitis predict development offexocrine insuficiency in chronic pancreatitis. Clin Gastroenterol Hepatol 2007;5:1085-1091
21. Witt H, Sahin-Tóth M, Landt O et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet 2006;38:668-673
22. Sharer N, Schwarz M, Malone G et al. Mutations of the cystic f brosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-652
23. Cohn J, Friedman K J, Pedar J N et al. Relation between mutations of the cystic fbrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339:653-658
24. Ockenga J, Stuhrmann M, Ballmann M et al. Mutationsofthe cystic f brosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol 2000; 95: 2061-2067
25. Truninger K, Malik N, Ammann RW et al. Mutations of the cystic f brosis gene in patients with chronic pancreatitis. Am J Gastroenterol 2001;96:2657-2661
26. Malats N, Real F X. Correction: mutations of the cystic fbrosis gene in patients with chronic pancreatitis. N Engl J Med 1999;340:1592-1593
27. Taylor CJ. Chronic pancreatitis and mutations of the cystic fbrosis gene. Gut 1999;44:29-32.
28. Gelrud A, Sheth S, Banerjee S et al. Analysis of cystic f brosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am J Gastroenterol 2004;99:1557-1562
29. Witt H, Luck W, Hennies HC et al. Mutations in the gene encoding the ser-ine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nature Genet 2000;25:213-216
30. Chen J, Mercier B, Audrezet M et al. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 2000;37:67-69
31. Pfutzer R H, Barmada M M, Brunskill A P J et al. SPINK1/PSTI polimor-phisms act as disease modiffers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-623
32. Treadgold J, Greenhalf W, Ellis I et al. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 2002;50:675-681
33. Drenth JP, te Morsche R, Jansen JB. Mutations in serine protease inhibitor Kaza l type 1 are strongly associated with chronic pancreatitis. Gut 2002;50:687-692
34. Kume K, Masamune A, Mizutamari H et al. Mutations in the serine protease inhibitor Kazal Type 1 (SPINK1) gene in Japanese patients with pancreatitis. Pancreatology 2005;5:354-360
35. Rosendahl J, Witt H, Szmola R et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008;40:78-82.
36. Masson E, Chen J-M, Scotet V et al. Association of rare chymotrypsinogen C ( CTRC ) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet 2008;23:83-91.
37. Gaia E, Salacone P, Gallo M et al. Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients. Dig Dis Sci 2002;47:2416-2421
38. Perri F, Piepoli A, Stanziale P et al. Mutation analysis of the cystic f brosis transmembrane conductance regulator (CFTR) gene, the cationic trypsino-gen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur J Hum Genet 2003;11:687-692
39. Pezzilli R, Morselli-Labate AM, Mantovani V et al. Mutations of the CFTR gene in pancreatic disease. Pancreas 2003;27:332-336
40. Gomez-Lira M, Bonamini D, Castellani C et al. Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients. Eur J Hum Genet 2003;11:543-546
41. Saurer L, Reber P, Schafner Th et al. D ifferential expression of chemok-ines in normal pancreas and in chronic pancreatitis. Gastroenterology 2000;118:356-367
42. Vonlaufen A, Apte M V, Imhof B A et al.The role of inflammatory and parenchymal cells in acute pancreatitis. J Pathol 2007; 213: 239-248
43. Andoh A, Takaya H, Saotome Th et al. Cytokine regulation of chemokine (IL-8, MCP-1 and RANTES) gene expression in human pancreatic periaci-nar myofbroblast. Gastroenterology 2000;119:211-219
44. Michalski C W, Gorbachevski A, Erkan M et al. Mononuclear cells modulate the activity of pancreatic stellate cells, which in turn promote f brosis and infammation in chronic pancreatitis. J Transl Med 2007;5:63.
45. Ito T. Can measurement of chemokines become useful biological and functional markers offearly-stage chronic pancreatitis? J Gastroenterol 2007; 42: 72-77
46. Grady T, Liang P, Ernst S A et al. Chemokine gene expression in rat pancreatic acinar cells in an early event associated with acute pancreatitis. Gastroenterology 1997;113:1966-1975
47. Pedersen N, Larsen S, Seidelin JB et al. Alcohol modulates circulating levels of interleukin 6 and monocyte chemoattractant protein-1 in Chronic Pancreatitis. Scand J Gastroenterol 2004;3:277-282
48. Rau B, Baumgart K, Krüger C M et al. CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications. Intensive Care Med 2003;29:622-629
49. Inoue M, Ino Y, Gibo J et al. The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats. Pancreas 2002;25:64-70.
50. Zhao H F, Ito T, Gibo J et al. Anti-monocyte chemoattractant protein 1 gene theraphy attenuates experimental chronic pancreatitis induced by dibutyl-tin dichloride in rats. Gut 2005;54:1759-1767
51. Rovin B H, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem and Biophys Res Comm 1999; 259: 344-348
52. Brady M, Bhatia M, Christmas S et al. Expression of the chemokines MCP-1/JE and cytokine-induced neutrophil chemoattractant in early acute pancreatitis. Pancreas 2002;25:260-269
53. Bhatia M, Brady M, Kang Y K et al. MCP-1 but not CINC synthesis is increased in rat pancreatic acini in response to cerulein hyperstimulation. Am J Physiol Gastrointest Liver Physiol 2002; 282: 77-85.
54. Ishibashi T, Zhao H, Kawabe K et al. Blocking of monocyte chemoattract-ant protein-1 (MCP-1) activity attenuates the severity oflacute pancreatitis in rats. J Gastroenterol 2008;43:79-85.
55. Papachristou G I, Sass D A, Avula H et al. Is the monocyte chemotactic protein-1-2518 G allele a risk factor for severe acute pancreatitis? Clin Gastroenterol Hepatol 2005;3:475-481
56. Kanda H, Tateya S, Tamori Y et al. MCP-1 contributes to macrophage inf ltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116:1494-1505
57. Sartipy P, Loskutof DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci 2003;100:7265-7270
58. Kim C S, Park H S, Kawada Th et al. Circulating levels of MCP1 and IL8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes 2006; 30: 1347-1355
59. Papachristou G I, Papachristou D J, Avula H et al. Obesity increases the severity oflacute pancreatitis: performance oflaPACHE-O score and correlation with the inflammatory response. Pancreatology 2006;6:279-285
60. Sass D A, Papachristou G I, Lamb J et al. The MCP-1 polymorphism is not a suscepibility factor for chronic pancreatitis. Pancreatology 2006; 6: 297-300.
61. Lee S H, Ryu J K, Jeong J B et al. Polymorphisms of the MCP1 and HSP70-2 genes in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci 2008;53:1721-1727
62. Teich N, Bauer N, Mössner J et al. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol 2002;97:341-346
63. Armitage P. Statistical Methods in Medical Research. Italian edn, Feltrinelli G: Milan, 1975.
64. Levy P, Barthet M, Mollard B R et al. Estimation of the prevalence and incidence of chronic pancreatitis and its complications. Gastroenterol Clin Biol 2006;30:838-844
65. Tuluvath P J, Imperio D, Nair S et al. Chronic pancreatitis. Long-term pain relief with or without surgery, cancer risk, and mortality. J Clin Gastroen-terol 2003;36:159-165
66. Lin Y, Tamakoshi A, Hayakawa Th et al. Associations oflalcohol drinking and nutrient intake with chronic pancreatitis: f ndings from a case-control study in Japan. Am J Gastroenterol 2001;96:2622-2627
67. Tinto A, Lloyd D A, Kang J Y et al. Acute and chronic pancreatitis\-diseases on the rise: a study of hospital admissions in England 1989/90-1999/2000. Aliment Pharmacol Ter 2002;16:2097-2105
68. Frulloni L, Gabbrielli A, Pezzilli R et al. Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis 2009;41:311-317